Indegene Ltd

Indegene Limited

Indegene Limited has informed BSE about the cessation of a Non-Executive Non-Independent Director.

Indegene Limited

Indegene Limited has informed BSE about the cessation of a Non-Executive Non-Independent Director.

Indegene Limited

Indegene Limited has informed BSE about the cessation of a Non-Executive Non-Independent Director.

Indegene Limited

Indegene Limited has informed BSE about the cessation of a Non-Executive Non-Independent Director.

Indegene Limited

Indegene Limited has informed BSE about the cessation of a Non-Executive Non-Independent Director.

Indegene Limited

Indegene Limited has informed BSE about the cessation of a non-executive, non-independent director.

Indegene Limited

Indegene Limited has informed BSE about the cessation of a Non-Executive Non-Independent Director. The details of the cessation are not provided in the announcement.

Indegene Ltd

Indegene Ltd announced the resignation of Mr. Mark Francis Dzialga as Non-Executive Non-Independent Director, effective October 29, 2026, due to the sale of the entire shareholding in the Company held by Brighton Park Capital and its affiliated investment vehicles.

Indegene Ltd

Indegene Ltd has issued a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming compliance for the quarter ended September 30, 2026.

Indegene Ltd

Indegene Ltd has informed about the allotment of 16,110 equity shares under the ESOP Scheme 2020, which will rank pari-passu with existing equity shares.

Indegene Ltd

Indegene Ltd has announced the success of its Digital Summit 2026, which attracted 120+ senior pharma leaders and featured keynotes, panels, and presentations on AI adoption and enterprise transformation in the life sciences industry.

Indegene Ltd

Indegene Ltd has announced the schedule of its Q2 FY27 earnings conference call, to be held on 30th October 2026 at 8:00 AM IST. The call will be attended by senior management, including Manish Gupta and Suhas Prabhu.

Indegene Ltd

Indegene Ltd has scheduled a Board Meeting on 29/10/2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 along with the Limited Review Report of the Auditors thereon.

Indegene Ltd

Indegene Ltd has announced the closure of its trading window for the quarter and half year ended September 30, 2026, due to the finalization and approval of financial results. The trading window will reopen 48 hours after the results are declared and disseminated to the stock exchanges.

Indegene Ltd

Indegene Ltd hosted its eighth Digital Summit, focusing on operationalizing AI for enterprise outcomes in the life sciences industry.

Indegene Ltd

Indegene Ltd has received preliminary approval from the US District Court for a proposed class action settlement against its wholly-owned subsidiary, Indegene, Inc. The settlement framework provides for a maximum settlement fund of approximately USD 4.72 million, payment of USD 250 per eligible approved claim, and retention/reversion to the defendants of amounts not required to satisfy approved claims.

Indegene Ltd

Indegene Ltd has announced an investors and analysts meeting on August 24-25, 2026, to discuss unpublished price sensitive information. The meeting will be held online and in-person in Bengaluru, and the details are available on the company's website.

Indegene Ltd

Indegene Ltd has provided an update on a class-action lawsuit against its wholly-owned subsidiary, Indegene, Inc., related to alleged violations of the U.S. Telephone Consumer Protection Act, 1991. The company has substantially concluded negotiations on a definitive settlement agreement, which remains subject to execution by the relevant parties and approval of the U.S. District Court.

Indegene Ltd

Indegene Ltd held its 28th Annual General Meeting on August 13, 2026, through video conference, in accordance with Ministry of Corporate Affairs and SEBI circulars. The meeting was attended by the company's management, directors, and shareholders. The agenda included introductions by the directors, a review of the company's performance, and discussions on various topics.

Indegene Ltd

Indegene Ltd has appointed Ms. Jill Mary De Simone as an independent director of the company, effective January 22, 2026, for a term of 3 years.